DEBORAH PECK: Open Payments
NPI 1548282098 · GRAND BLANC, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,155 in 186 payments from 50 companies in 2025. Trend: 2023 $3,372 · 2024 $3,969 · 2025 $4,155
Food & beverage: $4,032Education: $140
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $421 |
| Genentech USA, Inc. | 18 | $364 |
| Novartis Pharmaceuticals Corporation | 17 | $305 |
| Daiichi Sankyo Inc. | 13 | $230 |
| AstraZeneca Pharmaceuticals LP | 9 | $196 |
| TerSera Therapeutics LLC | 8 | $163 |
| Merck Sharp & Dohme LLC | 7 | $139 |
| Aveo Pharmaceuticals, Inc. | 6 | $122 |
| GENZYME CORPORATION | 5 | $117 |
| GlaxoSmithKline, LLC. | 4 | $95 |
Products named: ERLEADA, KISQALI, Venclexta, Enhertu, KEYTRUDA, Zoladex, FOTIVDA, Tecentriq.
Industry payments across MI — which companies pay providers there.
